As of May 27
| +0.31 / +0.34%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 147.00, with a high estimate of 165.00 and a low estimate of 22.61. The median estimate represents a +62.47% increase from the last price of 90.48.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.